Summary
This study evaluates the therapeutic potential of chronic treatment with synthetic cannabinoid HU210 and nicotine to slow photoreceptor degeneration in P23H-3 rat models of retinitis pigmentosa, using electroretinography and immunohistochemistry as outcome measures. Findings may inform future neuroprotective strategies for patients with inherited retinal degenerative diseases for whom no curative treatment currently exists.
Categories
Eye Health & Vision: Investigates neuroprotective effects of synthetic cannabinoid HU210 and nicotine on photoreceptor degeneration in a retinitis pigmentosa animal model.
Author(s)
C Altavilla
Publication Year
2015
Related Publications
Eye Health & Vision
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
- Melanopsin and rod–cone photoreceptors play different roles in mediating pupillary light responses during exposure to continuous light in humans
- Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types
- Intrinsically photosensitive melanopsin retinal ganglion cell contributions to the pupillary light reflex and circadian rhythm